Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma

Takafumi Narisawa1, Sei Naito2, Hiromi Ito2

  • 1Department of Urology, Yamagata University Faculty of Medicine, 2-2-2 Iida-nishi, Yamagata, 990-9585, Japan. tnari_0623@yahoo.co.jp.

BMC Cancer
|February 21, 2023
PubMed
Abstract

Insights

Fibroblast growth factor receptor 4 (FGFR4) gene amplification drives clear cell renal cell carcinoma (ccRCC) growth. Inhibiting FGFR4 suppressed tumor progression, identifying it as a promising therapeutic target for ccRCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Clear cell renal cell carcinoma (ccRCC) frequently exhibits fibroblast growth factor receptor 4 (FGFR4) gene copy number (CN) gains.
  • The functional role of FGFR4 CN amplification in ccRCC pathogenesis requires elucidation.

Purpose of the Study:

  • To investigate the functional significance of FGFR4 CN amplification in ccRCC.
  • To evaluate FGFR4 as a potential therapeutic target in ccRCC.

Main Methods:

  • Assessed correlation between FGFR4 CN (real-time PCR) and protein expression (western blotting, immunohistochemistry) in ccRCC cell lines and clinical specimens.
  • Utilized RNA interference and a selective FGFR4 inhibitor (BLU9931) to assess effects on ccRCC cell proliferation and survival (MTS assays, western blotting, flow cytometry).
  • Evaluated BLU9931 efficacy in a ccRCC xenograft mouse model.

Main Results:

  • FGFR4 CN amplification was observed in 60% of ccRCC specimens and correlated positively with protein expression.
  • FGFR4 amplification was present in ccRCC cell lines but not in a papillary RCC cell line (ACHN).
  • FGFR4 inhibition led to apoptosis and suppressed proliferation in ccRCC cells, with BLU9931 showing tumor suppression in vivo at tolerable doses.

Conclusions:

  • FGFR4 amplification promotes ccRCC cell proliferation and survival.
  • Targeting FGFR4 represents a potential therapeutic strategy for ccRCC patients with FGFR4 amplification.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K